Lise Margrete Thomassen
Position
PhD Candidate
Affiliation
Publications
Academic article
- Mohammed Khalid Al-Shibli; Lars T. Fadnes; Hege Berg Henriksen et al. (2025). Experiences with healthy eating among individuals with opioid dependence: insights from a dietary assessment. (external link)
- Rahim Mohammad Naimi; Mark Krogh Hvistendahl; Lise Margrete Thomassen et al. (2021). Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study. (external link)
- Therese Hjorth; Alena Schadow; Ingrid Revheim et al. (2022). Sixteen-week multicentre randomised controlled trial to study the effect of the consumption of an oat beta-glucan-enriched bread versus a whole-grain wheat bread on glycaemic control among persons with pre-diabetes: a study protocol of the CarbHealth study. (external link)
- Elaheh Javadi Arjmand; Lise Margrete Thomassen; Karl Trygve Druckrey-Fiskaaen et al. (2025). The effect of fruit smoothie supplementation on psychological distress and biomarkers among people with opioid dependence receiving opioid agonist therapy: a randomized controlled trial. (external link)
Conference poster
- J. Wiis; Lise Margrete Thomassen (tidligere: Wangen); A. Perner (2021). Nutrition gap after discharge from maximized intensive care nutritional therapy. (external link)
- Lise Margrete Thomassen (tidligere: Wangen); Rahim Mohammad Naimi; Hanna Skaraas Johnsen et al. (2019). Not all Patients with Short Bowel Syndrome and Colon in Continuity have Elevated Fasting and Postprandial Responses of GLP-1 and GLP-2: A Post Hoc Analysis. (external link)
- Hanna Skaraas Johnsen; Rahim Mohammad Naimi; Lise Margrete Thomassen (tidligere: Wangen) et al. (2019). The Clinical Value of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Patients with Short Bowel Syndrome and Colon in Continuity: An Open-Label Pilot Study. (external link)
Conference lecture
- Lise Margrete Thomassen (tidligere: Wangen); Rahim Mohammad Naimi; Hanna Skaraas Johnsen et al. (2020). Not all patients with short bowel syndrome and colon in continuity have elevated fasting and postprandial responses of GLP-1 and GLP-2: A post-hoc analysis. (external link)
- Hanna Skaraas Johnsen; Rahim Mohammad Naimi; Lise Margrete Thomassen (tidligere: Wangen) et al. (2020). The Clinical Value of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Patients with Short Bowel Syndrome and Colon in Continuity: An Open-Label Pilot Study. (external link)